Skip Navigation

JNCI Journal of the National Cancer Institute 1999 91(10):815;
© 1999 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 91, No. 10, 815, May 19, 1999
© 1999 Oxford University Press

IN THIS ISSUE

Treating Institution and Testicular Cancer Survival

To determine whether there is an association between the long-term clinical outcome of patients with metastatic germ cell cancer, particularly those with a poor prognosis, and the experience of the treating institution, Collette et al. (p. 839) analyzed data on 380 patients at 49 institutions in Europe who were enrolled in a randomized clinical trial of chemotherapy for this disease. The authors report that patients treated in institutions that entered fewer than five patients into the trial had statistically significant worse survival than patients . . . [Full Text of this Article]

Costs of Patients in Clinical Trials

Trichloroethylene and Kidney Cancer

Chronic Lymphocytic Leukemia Trials

Tangled Web of Factors Affecting Screening Mammography

A Prognostic Marker in Colorectal Cancer

Possible Bladder Cancer Suppressor Gene


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?